Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 15, 2019

SELL
$48.76 - $63.23 $95,910 - $124,373
-1,967 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $117,862 - $135,683
1,967 New
1,967 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track American Beacon Advisors, Inc. Portfolio

Follow American Beacon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Beacon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American Beacon Advisors, Inc. with notifications on news.